Growing Government Focus on Immunization Programs
The anti-infective vaccines market is predicted to develop due to a broad coalition of governments striving to raise awareness of the benefits of vaccination through immunisation programs with the goal of preventing the spread of communicable illnesses that are linked with high morbidity and mortality. For example, the ‘Immunize Australia Program’ funds individual immunisation, which serves as a preventative measure in reducing illness onset and limiting illness transmission, therefore sparing millions of Australians from serious diseases. The growing significance of government and non-government organisations in this industry is likely to give the vertical a significant boost. UNICEF and the WHO have released guidelines for developing a national immunisation plan, known as the Comprehensive Multi-Year Plan (cMYP), for all countries around the world, with the goal of ensuring equitable access to vaccination facilities for all people and increasing stakeholder participation in meeting vaccination coverage targets by designing and implementing feasible financial strategies.

Which Factors are Driving the Global Anti-Infective Vaccines Market?

  • Growing Vaccination Awareness to Boost Anti-Infective Vaccines Market
  • Increasing Incidence of Infectious Diseases
  • Rising R&D Activities to Fuel Anti-Infective Vaccines Market Growth Through 2031
  • Growing Government Focus on Immunization Programs


What are the Market Opportunities for Global Anti-Infective Vaccines Market?

  • Growing Government Support to Offer Lucrative Growth Prospects
  • Emerging Infectious Diseases to Offer Lucrative Growth Prospects
  • Increasing Vaccine Penetration Coverage


Discover how to stay ahead
Our 370+ page report provides 500+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Anti-Infective Vaccines Market. See how to exploit the opportunities.

Forecasts to 2031 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints, and challenges), PEST Analysis, Porter’s Five Forces, SWOT Analysis, product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and sub-markets

Product Type

  • Live/Attenuated Vaccines
  • Inactivated Vaccines
  • DNA & Recombinant Vector Vaccines
  • Others


Disease Type
Bacterial Diseases

  • Typhoid Vaccines
  • Tuberculosis Vaccines
  • Tetanus & Diphtheria Vaccines
  • Others

Viral Diseases

  • Influenza Vaccines
  • Hepatitis Vaccines
  • Polio Vaccines
  • Others


Distribution Channel

  • Hospitals Clinics
  • Public Hospitals
  • Private Clinics
  • Retail Pharmacies and Drug Stores
  • E-commerce


In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

By Region
North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC
  • South Africa
  • Rest of Middle East & Africa